An Integrated Clinico-transcriptomic Approach Identifies a Central Role of the Heme Degradation Pathway for Septic Complications after Trauma

Ann Surg. 2016 Dec;264(6):1125-1134. doi: 10.1097/SLA.0000000000001553.

Abstract

Objective: The present study was aimed to identify mechanisms linked to complicated courses and adverse events after severe trauma by a systems biology approach.

Summary background data: In severe trauma, overwhelming systemic inflammation can result in additional damage and the development of complications, including sepsis.

Methods: In a prospective, longitudinal single-center study, RNA samples from circulating leukocytes from patients with multiple injury (injury severity score ≥17 points; n = 81) were analyzed for dynamic changes in gene expression over a period of 21 days by whole-genome screening (discovery set; n = 10 patients; 90 samples) and quantitative RT-PCR (validation set; n = 71 patients, 517 samples). Multivariate correlational analysis of transcripts and clinical parameters was used to identify mechanisms related to sepsis.

Results: Transcriptome profiling of the discovery set revealed the strongest changes between patients with either systemic inflammation or sepsis in gene expression of the heme degradation pathway. Using quantitative RT-PCR analyses (validation set), the key components haptoglobin (HP), cluster of differentiation (CD) 163, heme oxygenase-1 (HMOX1), and biliverdin reductase A (BLVRA) showed robust changes following trauma. Upregulation of HP was associated with the severity of systemic inflammation and the development of sepsis. Patients who received allogeneic blood transfusions had a higher incidence of nosocomial infections and sepsis, and the amount of blood transfusion as source of free heme correlated with the expression pattern of HP.

Conclusions: These findings indicate that the heme degradation pathway is associated with increased susceptibility to septic complications after trauma, which is indicated by HP expression in particular.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Blood Proteins / genetics*
  • Cross Infection / blood*
  • Cross Infection / etiology*
  • Female
  • Gene Expression
  • Humans
  • Injury Severity Score
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prospective Studies
  • Real-Time Polymerase Chain Reaction
  • Risk Assessment
  • Risk Factors
  • Sepsis / blood*
  • Sepsis / etiology*
  • Transcriptome / genetics*
  • Transfusion Reaction
  • Wounds and Injuries / complications*

Substances

  • Biomarkers
  • Blood Proteins